Navigant Acquires Easton Associates

Navigant

announced today that it has acquired the business of Easton Associates (Easton), an international consulting firm specializing in product and business strategy for companies in the life sciences industries. The addition of more than 40 Easton professionals creates a team of more than 90 total Navigant professionals focused on services for the intensely competitive and highly regulated life sciences industry. Easton professionals are based in several of Navigant's existing locations including New York, Chicago and London. “This combination of two highly regarded firms in the life sciences market adds new capabilities and scale to the benefit of our valued clients,” said Eduardo Schur, Managing Director and leader of Navigant's Life Sciences practice. “Additionally, the combination of our talents in concert with our Healthcare payer and provider practices will result in a broad spectrum of services to address increased complexities in pharmaceutical, biotech, medical device and diagnostic industries. Our collective experience, innovative capacity and ability to understand current and future trends will be a timely asset to our clients.” Founded in 2000, Easton assists clients with business strategy development, opportunity assessment, due diligence, R&D portfolio management, new business planning, new product planning and related issues. The significant expertise of Easton's professionals, many of whom have advanced degrees in medicine and pharmaceutical science, has led to multiple longstanding client relationships with large pharmaceutical firms, specialty pharmaceutical companies, biotech firms and medical and diagnostic device companies.